David Cassiman

11.9k total citations
211 papers, 5.9k citations indexed

About

David Cassiman is a scholar working on Surgery, Epidemiology and Molecular Biology. According to data from OpenAlex, David Cassiman has authored 211 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Surgery, 52 papers in Epidemiology and 49 papers in Molecular Biology. Recurrent topics in David Cassiman's work include Liver Disease Diagnosis and Treatment (46 papers), Liver Disease and Transplantation (28 papers) and Health Systems, Economic Evaluations, Quality of Life (22 papers). David Cassiman is often cited by papers focused on Liver Disease Diagnosis and Treatment (46 papers), Liver Disease and Transplantation (28 papers) and Health Systems, Economic Evaluations, Quality of Life (22 papers). David Cassiman collaborates with scholars based in Belgium, Netherlands and United States. David Cassiman's co-authors include Tania Roskams, Louis Libbrecht, Valeer Desmet, Frederik Nevens, Chris Verslype, Carl Denef, Jos van Pelt, Wim Laleman, Steven Simoens and Peter Witters and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.

In The Last Decade

David Cassiman

199 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Cassiman Belgium 43 2.0k 1.8k 1.8k 1.6k 644 211 5.9k
Sumio Kawata Japan 45 1.8k 0.9× 1.0k 0.6× 2.0k 1.1× 1.8k 1.1× 472 0.7× 181 6.1k
Claus Niederau Germany 40 1.9k 0.9× 2.0k 1.1× 2.6k 1.4× 698 0.4× 627 1.0× 157 7.1k
Carolin Lackner Austria 41 1.5k 0.7× 2.4k 1.3× 2.9k 1.6× 1.6k 1.1× 441 0.7× 98 7.6k
Arthur Zimmermann Switzerland 53 1.8k 0.9× 2.0k 1.1× 1.5k 0.8× 2.6k 1.7× 379 0.6× 181 7.6k
Hartmut Schmidt Germany 46 1.1k 0.6× 1.7k 0.9× 1.6k 0.9× 3.8k 2.4× 683 1.1× 360 9.2k
Hitoshi Kohno Japan 40 1.9k 1.0× 1.5k 0.8× 1.0k 0.6× 1.2k 0.8× 191 0.3× 135 5.2k
Dina Tiniakos Greece 40 2.3k 1.1× 1.1k 0.6× 4.3k 2.4× 1.4k 0.9× 1.1k 1.7× 155 7.0k
Takumi Kawaguchi Japan 45 2.9k 1.4× 1.6k 0.9× 4.2k 2.4× 2.2k 1.4× 1.2k 1.9× 290 8.4k
Luigi Bolondi Italy 36 1.4k 0.7× 1.1k 0.6× 1.7k 1.0× 1.8k 1.2× 240 0.4× 94 4.9k
Anwar Farhood United States 50 2.9k 1.4× 2.3k 1.3× 1.7k 1.0× 1.9k 1.2× 530 0.8× 93 8.5k

Countries citing papers authored by David Cassiman

Since Specialization
Citations

This map shows the geographic impact of David Cassiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cassiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cassiman more than expected).

Fields of papers citing papers by David Cassiman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cassiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cassiman. The network helps show where David Cassiman may publish in the future.

Co-authorship network of co-authors of David Cassiman

This figure shows the co-authorship network connecting the top 25 collaborators of David Cassiman. A scholar is included among the top collaborators of David Cassiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cassiman. David Cassiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Craemer, Sam De, et al.. (2025). Resolving Hexose-Phosphates by LC-MS Leads to New Insights in PGM1-CDG Pathophysiology. ACS Omega. 10(37). 43243–43251.
2.
Cassiman, David, Timothy M. Cox, Judith Bons, et al.. (2025). Safety and efficacy of pharmacological inhibition of ketohexokinase in hereditary fructose intolerance. Journal of Clinical Investigation. 135(6). 3 indexed citations
3.
4.
Brouwers, Martijn C.G.J. & David Cassiman. (2024). Rare monogenic causes of steatotic liver disease masquerading as MASLD. Journal of Hepatology. 80(6). e252–e253.
5.
Malenstein, Hannah van, Ina Jochmans, David Cassiman, et al.. (2023). Utility and prognostic value of diagnosing MAFLD in patients undergoing liver transplantation for alcohol‐related liver disease. Clinical Transplantation. 37(6). e14965–e14965. 5 indexed citations
6.
Vandenberghe, Rik, et al.. (2022). A case of vitamin B12 deficiency neurological syndrome in a young adult due to late-onset cobalamin C (CblC) deficiency: a diagnostic challenge. University of Zagreb University Computing Centre (SRCE). 1 indexed citations
7.
Peersman, Nele, et al.. (2022). Development and validation of diagnostic algorithms for the laboratory diagnosis of porphyrias. Journal of Inherited Metabolic Disease. 45(6). 1151–1162. 5 indexed citations
8.
Cassiman, David, Raili Kauppinen, Ming‐Jen Lee, et al.. (2022). EXPLORE B: A prospective, long‐term natural history study of patients with acute hepatic porphyria with chronic symptoms. Journal of Inherited Metabolic Disease. 45(6). 1163–1174. 14 indexed citations
9.
10.
Kampen, Kim R., Gianmarco Rinaldi, Mélanie Planque, et al.. (2020). Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth. Molecular Cancer Therapeutics. 20(1). 50–63. 57 indexed citations
11.
Bird, Matthew, Petra Windmolders, Ingrid Vander Elst, et al.. (2019). Oxygraphy Versus Enzymology for the Biochemical Diagnosis of Primary Mitochondrial Disease. Metabolites. 9(10). 220–220. 4 indexed citations
12.
Witters, Peter, David Cassiman, & Éva Morava. (2017). Nutritional Therapies in Congenital Disorders of Glycosylation (CDG). Nutrients. 9(11). 1222–1222. 36 indexed citations
13.
Verbeek, Jef, Matthias Lannoo, Eija Pirinen, et al.. (2014). Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. Gut. 64(4). 673–683. 65 indexed citations
14.
Pauwels, Steven, David Cassiman, & Pieter Vermeersch. (2012). Homogentisic acid interferes with the enzymatic assay and the jaffe method. Acta Clinica Belgica. 67(1). 62–62. 1 indexed citations
15.
Geluwe, Bart Van, Ina Jochmans, Nicolas Meurisse, et al.. (2011). Laboratory meld-based allocation of liver grafts: is the "sickest first" principle justified?. Transplant International. 24. 35–35. 2 indexed citations
16.
Picavet, Eline, Marc Dooms, David Cassiman, & Steven Simoens. (2011). Drugs for rare diseases – influence of orphan designation status on price. Value in Health. 14(7).
17.
Malenstein, Hannah van, Olivier Gevaert, Louis Libbrecht, et al.. (2010). A Seven-Gene Set Associated with Chronic Hypoxia of Prognostic Importance in Hepatocellular Carcinoma. Clinical Cancer Research. 16(16). 4278–4288. 49 indexed citations
18.
Witters, Peter, Marc Hoylaerts, Kathleen Freson, et al.. (2008). Preserved platelet function but plasmatic inhibition of platelets in cholestatic liver disease. Hepatology. 48(4).
19.
Pirenne, Jacques, Tania Roskams, John Brassil, et al.. (2005). Hypothermic machine persfusion of porcine livers. American Journal of Transplantation. 5. 216. 2 indexed citations
20.
Monbaliu, Diethard, Tania Roskams, Rita De Vos, et al.. (2005). Machine perfusion of marginal livers. American Journal of Transplantation. 5. 445–446. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumio Kawata Breakdown of academic impact, for papers by Claus Niederau Breakdown of academic impact, for papers by Carolin Lackner Breakdown of academic impact, for papers by Arthur Zimmermann Breakdown of academic impact, for papers by Hartmut Schmidt Breakdown of academic impact, for papers by Hitoshi Kohno Breakdown of academic impact, for papers by Dina Tiniakos Breakdown of academic impact, for papers by Takumi Kawaguchi Breakdown of academic impact, for papers by Luigi Bolondi Breakdown of academic impact, for papers by Anwar Farhood
Rankless by CCL
2026